Cytokinetics, Incorporated
Pembelian
Diupdate

Long - cytk on expansion breakout

175
Cytokintics looks great for a follow through on expansion breakout made a 2 month new high on surging volume due to being listed on the s&p smallcap 600 with last closing day being the largest in its range of the last 7-9 trading days. Buy stop in just above the breakout high with 1day expiry.

This stock is also undervalued, leading its peers with good fundamentals in recent headlines.
Trading ditutup: target tercapai
hit and run job before earnings

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.